InvestSMART

Next Science Limited (ASX: NXS) - ETF Exposure

DELISTED - Current share price for NXS : $0.145

NXS General Information +

ASX Code NXS
Website N/A
Industry/Sector Health Care Supplies
Market Cap ($M) n/a
NXS Share Price $0.145
Day High $0.145
Day Low $0.140
Last Close $0.145
NXS Share Price Movement - ( No change )
Prices as at 16:41, 12 Feb 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to NXS

Next Science Limited (NXS) is held across 1 ETF spanning strategies that include health care supplies exposure . Its weighting in those funds means performance can have an outsized influence - when NXS moves, funds like ERTH that hold it can move with it.

For more concentrated exposure, ETFs such as ERTH (BetaShares Climate Change Innovation ETF) allocate about 0.5% to NXS , while the average exposure across all 1 ETF that hold it is around 0.5% .

Top ETF holdings

Last updated: ETF data and holdings as at 3 August 2026

Own NXS directly or through an ETF?

How does holding Next Science Limited (NXS) shares directly compare to ETFs that include it?

NXS Direct
ERTH
ASX
Holdings 1 company 96 holdings
NXS Weight 100% 0.5%
Diversification Single Stock Broad
Annual Cost Brokerage only 0.55% p.a.
Approx. Yield - 0.07%
Star Ratings - starstar

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not NXS's direct yield. Annual cost uses each ETF's MER.

NXS Exposure on $10,000 investment

How a $10,000 investment in Next Science Limited (NXS) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Next Science Limited (NXS) Direct share $0.145 0% $0 $10,000
BetaShares Climate Change Innovation ETF (ERTH) Equity - Global Strategy $10.320 -0.19% -$19 $9,981

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Next Science Limited (NXS) ETFs

1 ETF hold Next Science Limited (NXS).

ETF NXS Weight MER Yield
BetaShares Climate Change Innovation ETF (ERTH) 0.5% 0.55% 0.07%

Next Science Limited (NXS) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Next Science Limited (NXS) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Next Science Limited (NXS) price-sensitive announcements

NXS - Notice of EGM and CEO & CFO Resignation
Next Science Limited (ASX:NXS) has announced an Extraordinary General Meeting (EGM) schedu
Next Science Limited (NXS)
23 Dec 2025 | 5:25 PM
NXS - Proposed voluntary delisting from ASX
Next Science Limited (NXS) has proposed a voluntary delisting from the Australian Securiti
Next Science Limited (NXS)
23 Dec 2025 | 12:56 PM
NXS - Grant of ASX Waiver to permit capital return
Next Science Limited announced that it has received a waiver from ASX Listing Rule 7.25, a
Next Science Limited (NXS)
23 Dec 2025 | 12:44 PM
NXS - Quarterly Activity Report & Appendix 4C - 30 September
Next Science Limited, a medical technology company focused on reducing biofilm-based infec
Next Science Limited (NXS)
30 Oct 2025 | 8:18 AM

Next Science Limited (NXS) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Next Science Limited (NXS)
ORDINARY FULLY PAID
 Health Care - Removal from Official List 11 Feb 2026 10:24AM $0.145 $0.145 fallen by 0%
Next Science Limited (NXS)
ORDINARY FULLY PAID
 Health Care - Payment Confirmation & Amended Delisting Date 10 Feb 2026 4:12PM $0.145 $0.145 fallen by 0%
Next Science Limited (NXS)
ORDINARY FULLY PAID
 Health Care - Update - Return of Capital - NXS 2 Feb 2026 9:50AM $0.145 $0.145 fallen by 0%
Next Science Limited (NXS)
ORDINARY FULLY PAID
 Health Care - Capital Return - Change of Payment Date 30 Jan 2026 4:11PM $0.145 $0.145 fallen by 0%
Next Science Limited (NXS)
ORDINARY FULLY PAID
 Health Care - Return of Capital - NXS 28 Jan 2026 3:02PM $0.145 $0.145 fallen by 0%
Next Science Limited (NXS)
ORDINARY FULLY PAID
 Health Care - General Meeting - Voting Results 28 Jan 2026 9:43AM $0.145 $0.145 fallen by 0%

NXS Directors

Name Position Start Date
Mr Grant Hummel Non-Executive Director 23 Aug 2023
Ms Katherine (Kathy) Ostin Non-Executive Director 24 Oct 2023
Ms Aileen Stockburger Non-Executive Director, Non-Executive Chairman 23 Oct 2018

Next Science Limited (NXS) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
16 Sep 2024 HALL(IV), Harry Issued Related Securities 1,814,394 $0.248 $450,000.000
16 Sep 2024 HALL(IV), Harry Issued Options 3,361,855 $0.134 $450,000.000
1 Nov 2023 STOCKBURGER, Aileen Issued Direct Shares 524,801 $0.420 $220,416.420

See all changes in directors' interest & trades for Next Science Limited (NXS) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

NXS Management

Name Position
Gillian Maria Nairn Company Secretary

NXS Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (NXS). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
104,552,184 (55.11%) Walker Group Holdings Pty Limited
56,019,939 (19.20%) Auckland Trust Company Limited
21,385,466 (7.32%) Thorney technologies Ltd

NXS Calendar of Events

Date Event
28 August 2026 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.